ES2076895A1 - Fimbrias-adhesivas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones. - Google Patents

Fimbrias-adhesivas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.

Info

Publication number
ES2076895A1
ES2076895A1 ES09400202A ES9400202A ES2076895A1 ES 2076895 A1 ES2076895 A1 ES 2076895A1 ES 09400202 A ES09400202 A ES 09400202A ES 9400202 A ES9400202 A ES 9400202A ES 2076895 A1 ES2076895 A1 ES 2076895A1
Authority
ES
Spain
Prior art keywords
type
fimbriae
adhesins
coli strains
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400202A
Other languages
English (en)
Other versions
ES2076895B1 (es
Inventor
Quesada Jorge Martinez
Garate Alberto Martinez
Pelaez Ricardo Palacios
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica y de Especialidades SA
Original Assignee
Industrial Farmaceutica y de Especialidades SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Farmaceutica y de Especialidades SA filed Critical Industrial Farmaceutica y de Especialidades SA
Priority to ES09400202A priority Critical patent/ES2076895B1/es
Priority to CA002141475A priority patent/CA2141475C/en
Priority to AU11503/95A priority patent/AU691221B2/en
Priority to EP95200257A priority patent/EP0666271B1/en
Priority to AT95200257T priority patent/ATE185814T1/de
Priority to PT95200257T priority patent/PT666271E/pt
Priority to DE69512808T priority patent/DE69512808T2/de
Priority to DK95200257T priority patent/DK0666271T3/da
Priority to JP7016819A priority patent/JP2851556B2/ja
Priority to BR9500546A priority patent/BR9500546A/pt
Publication of ES2076895A1 publication Critical patent/ES2076895A1/es
Application granted granted Critical
Publication of ES2076895B1 publication Critical patent/ES2076895B1/es
Priority to US09/128,484 priority patent/US6471966B1/en
Priority to GR20000400030T priority patent/GR3032332T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Paints Or Removers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

FIMBRIAS-ADHESINAS DE TIPO 1 Y P AISLADAS DE NUEVAS CEPAS DE E. COSI, PROCEDIMIENTO PARA SU OBTENCION Y APLICACIONES. LAS FIMBRIAS ADHESINAS TIENEN UN PESO MOLECULAR DE 2X105 Y 2X107 DA, Y COMPRENDEN 90-95 POR CIENTO DE PROTEINAS Y 1-3 POR CIENTO DE AZUCARES. LAS FIMBRIAS DE TIPO 1 MUESTRAN 5 FRACCIONES PROTEICAS DIFERENTES DE 14-20 KDA ESTANDO ASOCIADA LA MAYORIA A CARBOHIDRATOS. LAS FIMBRIAS DE TIPO P TAMBIEN INCLUYEN 5 FRACCIONES PROTEICAS DIFERENTES DE 14-20 KDA ESTANDO UNA DE LAS MAYORITARIAS ASOCIADA A CARBOHIDRATOS. EL PROCEDIMIENTO COMPRENDE: CULTIVAR CEPAS DE E. COLI CECT 4484 Y CECT 4485; RECOGER EL SEDIMENTO POR CENTRIFUGACION, RESUSPENDERLO EN SUERO FISIOLOGICO Y HOMOGENEIZAR; CENTRIFUGAR EL HOMOGENEIZADO RECOGIENDO EL SOBRENADANTE, QUE SE SOMETE A PRECIPITACION SALINA, RECONSTITUIR EL PRECIPITADO Y DIALIZAR LA SOLUCION; TRATAR EL DIALIZADO CON DESOXICOLATO SODICO Y, SOMETER EL PRODUCTO A DOS CROMATOGRAFIAS SUCESIVAS CON SEPHACRYL S-200 Y SEPHAROSA 4B. APLICACION EN EL TRATAMIENTO Y PREVENCION DE LAS INFECCIONES DEL TRACTO URINARIO PRODUCIDAS POR E. COLI FIMBRIADAS.
ES09400202A 1994-02-04 1994-02-04 Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones. Expired - Fee Related ES2076895B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES09400202A ES2076895B1 (es) 1994-02-04 1994-02-04 Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
CA002141475A CA2141475C (en) 1994-02-04 1995-01-31 Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
AU11503/95A AU691221B2 (en) 1994-02-04 1995-02-01 Type 1 and type P fimbriae-adhesins isolated from novel E coli strains, process for their preparation and uses thereof
DE69512808T DE69512808T2 (de) 1994-02-04 1995-02-02 Aus neuen E.Coli Stämmen isolierte Typ 1 und Typ P Fibrillen-Adhesine, Verfahren zu ihrer Herstellung und ihre Verwendungen
AT95200257T ATE185814T1 (de) 1994-02-04 1995-02-02 Aus neuen e.coli stämmen isolierte typ 1 und typ p fibrillen-adhesine, verfahren zu ihrer herstellung und ihre verwendungen
PT95200257T PT666271E (pt) 1994-02-04 1995-02-02 Adesinas de fimbrias de tipo 1 e de tipo p isoladas a partir de novas estirpes de e. coli processo para a sua preparacao e sua utilizacao
EP95200257A EP0666271B1 (en) 1994-02-04 1995-02-02 Type 1 and type P fimbriae-adhesins isolated from novel E. coli strains, process for their preparation and uses thereof
DK95200257T DK0666271T3 (da) 1994-02-04 1995-02-02 Type 1- og type P-fimbriae-adhæsioner isoleret fra nye E. coli-stammer, fremgangsmåde til deres fremstilling og deres anven
JP7016819A JP2851556B2 (ja) 1994-02-04 1995-02-03 新規なエシェリキア・コリ菌株から単離した１型およびｐ型フィムブリエ−アドヘシン、その製法ならびにその使用
BR9500546A BR9500546A (pt) 1994-02-04 1995-02-06 Fimbrias - adesinas e processo para a preparaçao de fimbrias - adesinas
US09/128,484 US6471966B1 (en) 1994-02-04 1998-08-04 Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
GR20000400030T GR3032332T3 (en) 1994-02-04 2000-01-12 Type 1 and type P fimbriae-adhesins isolated from novel E. coli strains, process for their preparation and uses thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400202A ES2076895B1 (es) 1994-02-04 1994-02-04 Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.

Publications (2)

Publication Number Publication Date
ES2076895A1 true ES2076895A1 (es) 1995-11-01
ES2076895B1 ES2076895B1 (es) 1996-08-16

Family

ID=8285106

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09400202A Expired - Fee Related ES2076895B1 (es) 1994-02-04 1994-02-04 Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.

Country Status (11)

Country Link
EP (1) EP0666271B1 (es)
JP (1) JP2851556B2 (es)
AT (1) ATE185814T1 (es)
AU (1) AU691221B2 (es)
BR (1) BR9500546A (es)
CA (1) CA2141475C (es)
DE (1) DE69512808T2 (es)
DK (1) DK0666271T3 (es)
ES (1) ES2076895B1 (es)
GR (1) GR3032332T3 (es)
PT (1) PT666271E (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512817A (ja) * 2000-03-10 2004-04-30 アンスティテュ　ナショナル　ド　ラ　サンテ　エ　ド　ラ　ルシェルシュ　メディカル　（イ．エヌ．エス．エ．エール．エム．） 大腸菌から単離される、ｂ２／ｄ＋ａ−型のポリヌクレオチド、ならびにこれらのポリヌクレオチドとそのポリペプチドの生物学的使用
EP1342784A1 (en) * 2002-03-06 2003-09-10 Mutabilis S.A. ExPEC-specific proteins, genes encoding them and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102831A1 (en) * 1982-09-02 1984-03-14 Unilever N.V. Production of antibodies
WO1986004604A1 (en) * 1985-01-31 1986-08-14 Slagteriernes Forskningsinstitut A 987p fimbriae-producing microorganism, a vaccine for the immunization of pigs as well as a method for production of the vaccine
EP0249739A1 (en) * 1986-06-18 1987-12-23 Bactex Incorporated Vaccine composition for immunization against urinary tract infection caused by E. coli

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000614A1 (en) * 1988-07-13 1990-01-25 Baylor College Of Medicine Receptor specific proteins and their use in receptor typing
DE3832785A1 (de) * 1988-09-27 1990-04-19 Max Planck Gesellschaft Verfahren zur gewinnung von p-adhaesin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0102831A1 (en) * 1982-09-02 1984-03-14 Unilever N.V. Production of antibodies
WO1986004604A1 (en) * 1985-01-31 1986-08-14 Slagteriernes Forskningsinstitut A 987p fimbriae-producing microorganism, a vaccine for the immunization of pigs as well as a method for production of the vaccine
EP0249739A1 (en) * 1986-06-18 1987-12-23 Bactex Incorporated Vaccine composition for immunization against urinary tract infection caused by E. coli

Also Published As

Publication number Publication date
DK0666271T3 (da) 2000-04-17
EP0666271A1 (en) 1995-08-09
CA2141475C (en) 1999-08-24
JPH0834798A (ja) 1996-02-06
GR3032332T3 (en) 2000-04-27
AU691221B2 (en) 1998-05-14
JP2851556B2 (ja) 1999-01-27
ES2076895B1 (es) 1996-08-16
ATE185814T1 (de) 1999-11-15
EP0666271B1 (en) 1999-10-20
CA2141475A1 (en) 1995-08-05
PT666271E (pt) 2000-04-28
DE69512808D1 (de) 1999-11-25
DE69512808T2 (de) 2000-06-15
BR9500546A (pt) 1997-05-27
AU1150395A (en) 1995-08-17

Similar Documents

Publication Publication Date Title
IL142691A (en) Use of an antibody which binds to ailim protein in the manufacture of medicament for preventing, treating or prophylaxis of graft versus host reaction
ES2811101T3 (es) Procedimiento para la preparación y purificación de la sal de sodio de ácido hialurónico
NZ511956A (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
US11672833B2 (en) Edible bird's nest extract and method of extraction
KR910004209A (ko) 에스케리키아 콜리 왁진
EP0326149B1 (en) Adjuvant for cancer immunotherapy
ES2076895A1 (es) Fimbrias-adhesivas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
WO2002068477A1 (en) Highly sulfated derivatives of k5 polysaccharide and their preparation
AU2002236118A1 (en) Highly sulfated derivatives of K5 polysaccharide and their preparation
CN101486758B (zh) mda-7/IL-24突变体多肽及其制备方法及用途
PL316935A1 (en) Heparin bonding protein for treating septicaemia and method of obtaining such protein
AU2003285286A1 (en) Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)
JPS6153220A (ja) 新規多糖体ｒｏｎ物質，その製造法およびそれを有効成分とする抗腫瘍剤，免疫調節剤並びに感染症予防治療剤
AU631674B2 (en) Pokeweed antiviral protein - monoclonal antibody conjugates
JPH0265790A (ja) 免疫賦活作用を有する粗糖蛋白質画分及びその製造法
JPH0770209A (ja) 多糖物質ｎｐｓ、その製造法および用途
US7241735B2 (en) Pharmacologically active polypeptide glycoconjugates
DE69724328T2 (de) Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease
JPS6153221A (ja) 新規多糖体ｒｉｎ物質，その製造法およびそれを有効成分とする抗腫瘍剤，免疫調節剤並びに感染症予防治療剤
KR100772007B1 (ko) 마크로파지 활성화 또는 항암용 알로에 조성물
佐々木康人 et al. Effect of Non-dialyzable Extract of Amaranth Seeds on Immunoglobulin Production and Proliferation of a Human-human Hybridoma Cell Line, HFlOB4.
Morris Heparin-Peptide Interactions
MX9604953A (es) Proteina que une heparina, para el tratamiento de sepsis y procesos para su preparacion.
JPS627919B2 (es)
IT1244774B (it) Processo per la preparazione di polisaccaridi di origine batterica

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19940204

Kind code of ref document: B1

Effective date: 19940204

PC2A Transfer of patent
PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180806